Compass Therapeutics Inc. (CMPX)
$2.40
$-0.12
(-4.76%)
As on 28-Aug-2026 16:17EDT
Market cap
$432 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.6 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-8.9
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.4
-
Face value
--
-
Shares outstanding
180,087,915
6 Years Aggregate
CFO
$-186.63 Mln
EBITDA
$-207.71 Mln
Net Profit
$-264.37 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Compass Therapeutics Inc (CMPX)
| -55.3 | 15.4 | 5.7 | -26.8 | 0.4 | -7.3 | -- |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Compass Therapeutics Inc (CMPX)
| 270.3 | -7.0 | -69.0 | 58.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Compass Therapeutics Inc (CMPX)
|
2.4 | 432.2 | 0.0 | -73.5 | -- | -40.5 | -- | 2.7 |
| 84.9 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 72.1 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 54.5 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 105.4 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 351.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 533.8 | 11,938.8 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 22.9 | |
| 600.7 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 344.8 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 | |
| 144.3 | 9,339.4 | 282.0 | 82.9 | -28.6 | 11.4 | 140.1 | 11.5 |
Shareholding Pattern
View DetailsAbout Compass Therapeutics Inc (CMPX)
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States. The company's lead product candidate, tovecimig, is a... bispecific antibody that targets delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A), which are critical to angiogenesis and tumor vascularization. It also develops CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells; CTX-8371, a bispecific inhibitor that targets programmed cell death protein-1 (PD-1) and ligand PD-L1 checkpoint inhibitor antibodies; and CTX-10726, a bispecific antibody that targets PD-1 and VEFG-A. The company was founded in 2014 and is headquartered in Boston, Massachusetts. Read more
-
Chief Executive Officer
Dr. Vered Bisker-Leib M.D., MBA, Ph.D.
-
Chief Executive Officer
Dr. Thomas J. Schuetz M.D., Ph.D.
-
Headquarters
Boston, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Compass Therapeutics Inc (CMPX)
What is the current share price of Compass Therapeutics Inc (CMPX) Today?
The share price of Compass Therapeutics Inc (CMPX) is $2.40 (NASDAQ) as of 28-Aug-2026 16:17 EDT. Compass Therapeutics Inc (CMPX) has given a return of 0.42% in the last 3 years.
What is the current PB & PE ratio of Compass Therapeutics Inc (CMPX)?
Since, TTM earnings of Compass Therapeutics Inc (CMPX) is negative, P/E ratio is not available.
The P/B ratio of Compass Therapeutics Inc (CMPX) is 2.74 times as on 28-Aug-2026, a 49 discount to its peers’ median range of 5.35 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-14.93 |
5.04 |
2024 |
-4.01 |
1.58 |
2023 |
-4.69 |
1.34 |
2022 |
-13.49 |
2.91 |
2021 |
-2.00 |
1.17 |
What is the 52 Week High and Low of Compass Therapeutics Inc (CMPX)?
The 52-week high and low of Compass Therapeutics Inc (CMPX) are Rs 6.88 and Rs 1.61 as of 30-Aug-2026.
What is the market cap of Compass Therapeutics Inc (CMPX)?
Compass Therapeutics Inc (CMPX) has a market capitalisation of $ 432 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Compass Therapeutics Inc (CMPX)?
Before investing in Compass Therapeutics Inc (CMPX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.